These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16734850)

  • 21. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition.
    Burger HG; Dudley EC; Cui J; Dennerstein L; Hopper JL
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2832-8. PubMed ID: 10946891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.
    Hara N; Takizawa I; Isahaya E; Nishiyama T; Hoshii T; Ishizaki F; Takahashi K
    Urol Oncol; 2012 Sep; 30(5):596-601. PubMed ID: 21458314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Are age and educational level the determinants of hormonal parameters considered as indices of andropause?].
    Jankowska EA; Szklarska A; Lopuszańska M; Medraś M
    Pol Merkur Lekarski; 2004 Apr; 16(94):323-7. PubMed ID: 15517925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female.
    Ali I; James T; Meston N; Wojnarowska F; Shine B
    Clin Chem Lab Med; 2009; 47(2):202-7. PubMed ID: 19191727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum androgen levels in black, Hispanic, and white men.
    Litman HJ; Bhasin S; Link CL; Araujo AB; McKinlay JB
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4326-34. PubMed ID: 16912139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial differences in prostate androgen levels in men with clinically localized prostate cancer.
    Mohler JL; Gaston KE; Moore DT; Schell MJ; Cohen BL; Weaver C; Petrusz P
    J Urol; 2004 Jun; 171(6 Pt 1):2277-80. PubMed ID: 15126802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gemfibrozil treatment is associated with elevated adrenal androgen, androstanediol glucuronide and cortisol levels in dyslipidemic men.
    Hautanen A; Mänttäri M; Manninen V; Adlercreutz H
    J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):307-13. PubMed ID: 7826893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
    Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SHBG levels are associated with bone loss and vertebral fractures in patients with prostate cancer.
    Varsavsky M; Reyes-García R; García-Martín A; González-Ramírez AR; Avilés-Perez MD; Muñoz-Torres M
    Osteoporos Int; 2013 Feb; 24(2):713-9. PubMed ID: 22588185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Concentrations of Sex Hormone-binding Globulin Vary Widely in Younger and Older Men: Clinical Data from a Men's Health Practice.
    Krakowsky Y; Conners W; Morgentaler A
    Eur Urol Focus; 2019 Mar; 5(2):273-279. PubMed ID: 28753796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone Recovery Profiles After Cessation of Androgen Deprivation Therapy for Prostate Cancer.
    Nascimento B; Miranda EP; Jenkins LC; Benfante N; Schofield EA; Mulhall JP
    J Sex Med; 2019 Jun; 16(6):872-879. PubMed ID: 31080102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in androgens during treatment with four low-dose contraceptives.
    Coenen CM; Thomas CM; Borm GF; Hollanders JM; Rolland R
    Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between pubertal gynecomastia, prostate specific antigen, free androgen index, SHBG and sex steroids.
    Kilic M; Kanbur N; Derman O; Akgül S; Kutluk T
    J Pediatr Endocrinol Metab; 2011; 24(1-2):61-7. PubMed ID: 21528817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
    Kjaer TN; Ornstrup MJ; Poulsen MM; Jørgensen JO; Hougaard DM; Cohen AS; Neghabat S; Richelsen B; Pedersen SB
    Prostate; 2015 Sep; 75(12):1255-63. PubMed ID: 25939591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum prostate-specific antigen levels reflect the androgen milieu in patients with localized prostate cancer receiving androgen deprivation therapy: Tumor malignant potential and androgen milieu.
    Takizawa I; Nishiyama T; Hara N; Isahaya E; Hoshii T; Takahashi K
    Prostate; 2010 Sep; 70(13):1395-401. PubMed ID: 20687212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High serum prostate-specific antigen levels in the absence of prostate cancer in Middle-Eastern men: the clinician's dilemma.
    Kehinde EO; Sheikh M; Mojimoniyi OA; Francis I; Anim JT; Nkansa-Dwamena D; Al-Awadi KA
    BJU Int; 2003 May; 91(7):618-22. PubMed ID: 12699471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.
    Travis RC; Key TJ; Allen NE; Appleby PN; Roddam AW; Rinaldi S; Egevad L; Gann PH; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjønneland A; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Sieri S; Vineis P; Palli D; Quirós JR; Ardanaz E; Chirlaque MD; Larrañaga N; Gonzalez C; Sanchez MJ; Trichopoulou A; Bikou C; Trichopoulos D; Stattin P; Jenab M; Ferrari P; Slimani N; Riboli E; Kaaks R
    Int J Cancer; 2007 Sep; 121(6):1331-8. PubMed ID: 17514649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testicular and adrenocortical function in men with prostatic cancer and in healthy age-matched controls.
    Carlström K; Stege R
    Br J Urol; 1997 Mar; 79(3):427-31. PubMed ID: 9117226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.